Induction of apoptosis in oral cancer cells by an anti-bcl-2 ribozyme delivered by an adenovirus vector

Clinical Cancer Research

Volumn 6, Issue 1, 2000, Pages 213-222

  Gibson, Sandra A ^a   Pellenz, Christopher ^a   Hutchison, Robert E ^a   Davey, Frederick R ^a   Shillitoe, Edward J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; PROTEIN BCL 2; RIBOZYME;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUTH CANCER; ONCOGENE; PRIORITY JOURNAL;

ADENOVIRIDAE; APOPTOSIS; BASE SEQUENCE; CELL DIVISION; CELL SURVIVAL; DNA FRAGMENTATION; GENETIC VECTORS; HUMANS; KINETICS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; RNA, CATALYTIC; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033978427     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Paterson, I. C., Eveson, J. W., and Prime, S. S. Molecular changes in oral cancer may reflect aetiology and ethnic origin. Oral Oncol., 32: 150-153, 1996.
2. Ke, L. D., Adler-Storthz, K., Clayman, G. L., Yung, A. W., and Chen, Z. Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck, 20: 320-327, 1998.
3. Sugerman, P. B., and Shillitoe, E. J. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis., 3: 130-147, 1997.
4. Jordan, R. C. K., Catzavelos, G. C., Barrett, A. W., and Speight, P. M. Differential expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Oral Oncol., 32: 394-400, 1996.
5. Drachenberg, C. B., Blanchaert, R., Ioffe, O. B., Ord, R. A., and Papadimitriou, J. C. Comparative study of invasive squamous cell carcinoma and verrucous carcinoma of the oral cavity: expression of bcl-2, p53, and Her-2/neu, and indexes of cell turnover. Cancer Detect. Prevent., 21: 483-489, 1997.
6. Singh, B. B., Chandler, F. W., Whitaker, S. B., and Forbes-Nelson, A. E. Immunohistochemical evaluation of bcl-2 oncoprotein in oral dysplasia and carcinoma. Oral Surg. Med. Pathol., 85: 692-698, 1998.
7. Yao, L., Iwai, M., and Furata, I. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol., 35: 56-62, 1999.
8. Birchall, M. A., Schock, E., Harmon, B. V., and Gobe, G. Apoptosis, mitosis, PCNA, and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: prospective, in vivo study. Oral Oncol., 33: 419-425, 1997.
9. Schoelch, M. L., Le, Q. T., Silverman, S., McMilan, A., Dekker, N. P., Fu, K. K., Ziober, B. L., and Regezi, J. A. Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Oral Oncol., 35: 77-85, 1999.
10. Chrysomali, E., Greenspan, J. S., Dekker, N., Greenspan, D., and Regezi, J. A. Apoptosis-associated proteins in oral hairy leukoplakia. Oral Dis., 2: 279-284, 1996.
11. Harada, H., Mitsuyasu, T., Seta, Y., Maruoka, Y., Toyoshima, K., and Yasumoto, S. Overexpression of bcl-2 protein inhibits terminal differentiation of oral keratinocytes in vitro. J. Oral Pathol. Med., 27: 11-17, 1998.
12. Seite, P., Hillion, J., d'Agay, M. F., Gaulard, P., Cazals, D., Badoux, F., Berger, R., and Larsen, C. J. BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases. Leukemia (Baltimore), 7: 410-417, 1993.
13. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
14. Reed, J. C., Meister, L., Tanaka, S., Cuddy, M., Yum, S., Geyer, C., and Pleasure, D. Differential expression of bcl2 proto-oncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res., 51: 6529-6538, 1991.
15. Stefanaki, K., Rontogiannis, D., Vamvouka, C., Bolioti, S., Chaniotis, V., Sotsiou, F., Vlychou, M., Delidis, G., Kakolyris, S., Georgoulias, V., and Kanavoros, P. Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas. Anticancer Res., 18: 1689-1695, 1998.
16. Valassiadou, K. E., Stefanaki, K., Tzardi, M., Datseris, G., Georgoulias, V., Melissas, J., Tsiftsis, D. D., Delides, G., and Kanavaros, P. Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas. Anticancer Res., 17: 2571-2576, 1997.
17. Selzer, E., Schlagbauer-Wadl, H., Okamoto, I., Pehamberger, H., Potter, R., and Jansen, B. Expression of bcl-2 family members in human melanocytes, in melanoma metastases and in melanoma cell lines. Melanoma Res., 8: 197-203, 1998.
18. Adams, J. M., and Corey, S. The bcl-2 protein family: arbiters of cell survival. Science (Washington DC), 281: 1322-1326, 1998.
19. Strasser, A., Harris, A. W., and Cory, S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell, 67: 889-899, 1991.
20. Sentman, C. L., Shutter, J. R., Hockenberry, D., Kanagawa, O., and Korsmeyer, S. J. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 67: 879-888, 1991.
21. Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H., and Cory, S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J., 14: 6136-6147, 1995.
22. Newton, L., and Strasser, A. The Bcl-2 family and cell death regulation. Curr. Opin. Genet. Dev., 8: 68-75, 1998.
23. Reed, J. C., Cuddy, M., Haldar, S., Croce, C. M., Nowell, P., Makover, D., and Bradley, K. BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. Proc. Natl. Acad. Sci. USA, 87: 3660-3664, 1990.
24. Cotter, F. E., Johnson, P., Hall, P.. Pocock, C., al Mahdi, N., Cowell, J. K., and Morgan, G. Antisense oligonucleotides suppress B-cell lymphoma growth in a SCID-hu mouse model. Oncogene, 9: 3049-3055, 1994.
25. Dorai, T., Olsson, C. A., Katz, A. E., and Buttyan, R. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer. Prostate, 32: 246-258, 1997.
26. Trapnell, B. C. Adenoviral vectors for gene transfer. Adv. Drug Delivery Rev., 12: 185-199, 1993.
27. Yei, S., Mittereder, N., Wert, S., Whitsett, J. A., Wilmott, R. W., and Trapnell, B. C. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Human Gene Ther., 5: 731-744, 1994.
28. Gibson, S. A., and Shillitoe, E. J. Ribozymes. Their functions and strategies for their use. Mol. Biotechnol., 7: 125-137, 1997.
29. Clayman, G. L., Trapnell, B. C., Mittereder, N., Liu, T. J., Eicher, S., Zhang, S., and Shillitoe, E. J. Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetration. Cancer Gene Ther., 2: 105-111, 1995.
30. Chen, Z., Kamath, P., Zhang, S., St. John, L., Adler-Storthz, K., and Shillitoe, E. J. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus cype 18. Cancer Gene Ther., 3: 18-23, 1996.
31. Seto, M., Jaeger, U., Hockett, R. D., Graninger, W., Bennett, S., Goldman. P., and Korsmeyer, S. J. Alternative promoters and exons, somatic mutation and deregulation of the BCL-2-lg fusion gene in lymphoma. EMBO J., 7: 123-131, 1988.
32. Denizot, F., and Lang, R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods, 89: 271-277, 1986.
33. Carmichael, J., Mitchell, J. B., DeGraff, W. G., Gamson, J., Gazdar, A. F., Johnson, B. E., Glatstein, E., and Minna, J. D. Chemosensitivity testing of human lung cancer cell lines using the MTT assay. Br. J. Cancer. 57: 540-547, 1988.
34. Shillitoe, E. J., Noonan, S., Hinkle, C. C., Marini, F. C., and Kellman, R. M. Transduction of normal and malignant oral epithelium by particle bombardment. Cancer Gene Ther., 5: 176-182, 1998.
35. Kitada, S., Miyashita, T., Tanaka, S., and Reed, J. C. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res. Dev., 3: 157-169, 1993.
36. Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., van Elsas, A., Muller, M., Wolff, K., Eichler, H. G., and Pehamberger, H. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med., 4: 232-234, 1998.
37. Shillitoe, E. J., and Noonan, S. Strength and specificity of different gene promoters in oral cancer cells. Oral Oncol., in press, 2000.
38. Overholt, S. M., Liu, T. J., Taylor, D. L., Wang, M., El-Naggar, A. K., Shillitoe, E. J., Adler-Storthz, K., St. John, L., Roth, J. A., and Clayman, G. L. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials. Curr. Top. Microbiol. Immunol., 3: 185-191, 1997.
39. Schantz, S. P., Zhang, Z. F., Spitz, M. S., Sun, M., and Hsu, T. C. Genetic susceptibility to head and neck cancer: interaction between nutrition and mutagen sensitivity. Laryngoscope, 107: 765-781, 1997.
40. Frisch, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
41. Frisch, S. M., Vuori, K., Kelaita, D., and Sicks, S. A role for Jun-N-terminal kinase in anoikis: suppression by bcl-2 and crmA. J. Cell Biol., 135: 1377-1382, 1996.
42. Reed, J. C. Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Adv. Pharmacol., 41: 501-532, 1997.
43. Hu, Z. B., Minden, M. D., and McCulloch, E. A. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells. Leukemia (Baltimore), 9: 1667-1673, 1995.
44. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Washington DC), 278: 1073-1077, 1997.
45. Feng, M., Cabrera, G., Deshane, J., Scanlon, K. J., and Curiel, D. T. Neoplastic reversion accomplished by high efficiency adenoviral-medi-ated delivery of an anti-ras ribozyme. Cancer Res., 55: 2024-2028, 1995.
46. Czubayko, F., Downing, S. G., Hsieh, S. S., Goldstein, D. J., Lu, P. Y., Trapnell, B. C., and Wellstein, A. Adenovirus-mediated transduction of ribozymes abrogates HER-2/neu and pleiotrophin expression and inhibits tumor cell proliferation. Gene Ther., 4: 943-949, 1997.
47. Ohta, Y., Kijima, H., Ohkawa, T., Kashani-Sabet, M., and Scanlon, K. J. Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucleic Acids Res, 24: 938-942, 1996.
48. Shore, S. K., Nabissa, P. M., and Reddy, E. P. Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. Oncogene, 8: 3183-3188, 1993.
49. Alvarez-Salas, L. M., Cullinan, A. E., Siwkowski, A., Hampel, A., and DiPaolo, J. A. Inhibition of HPV-16 E6/E7 immortalization of normal keratinocytes by hairpin ribozymes. Proc. Natl. Acad. Sci. USA, 95: 1189-1194, 1998.
50. Huang, S., Stupack, D., Mathias, P., Wang, Y., and Nemerow, G. Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes. Proc. Natl. Acad. Sci. USA, 94: 8156-8161, 1997.
51. Yamazaki, H., Kijima, H., Ohnishi, Y., Abe, Y., Oshika, Y., Tsuchida, T., Tokunaga, T., Tsugu, A., Ueyama, Y., Tamaoki, N., and Nakamura. M. Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression. J. Natl. Cancer Inst., 90: 581-587, 1998.
52. Li, M., Lonial, H., Citarella, R., Lindh, D., Colina, L., and Kramer, R. Tumor inhibitory activity of anti-ras ribozymes delivered by retroviral gene transfer. Cancer Gene Ther., 3: 221-229, 1996.
53. Scherr, M., Maurer, A. B., Klein, S., Ganser, A., Engels, J. W., and Grez, M. Effective reversal of a transformed phenotype by retrovirus-mediated transfer of a ribozyme directed against mutant N-ras. Gene Ther., 5: 1227-1234, 1998.
54. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.